NewAmsterdam Pharma Company N.V. Ordinary Shares Earnings

The next earnings date for NewAmsterdam Pharma Company N.V. Ordinary Shares is November 17, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of NewAmsterdam Pharma Company N.V. Ordinary Shares Earnings

Report DateEstimated Earnings Per Share
11/17/2025$-0.40

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

NewAmsterdam Pharma Company N.V. Ordinary Shares Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/07/2025Before Market$-0.1565.91%
05/12/2025---$-0.3422.00%
11/06/2024---$-0.1663.30%
08/07/2024---$-0.3828.18%
05/08/2024After Market$-1.06-100.00%
02/28/2024After Market$-0.541.82%
11/13/2023---$-0.5635.38%
08/07/2023Before Market$-1.01-140.48%
05/08/2023---$-0.44-2.69%
03/31/2023Before Market$-1.80-267.35%
10/18/2022After Market$-0.2776.38%
08/11/2022---$-0.07---
05/12/2022---$0.08---
03/25/2022---$0.05---
11/09/2021---$0.10---
08/09/2021---$-0.07---
05/24/2021---$0.16---

More About NewAmsterdam Pharma Company N.V. Ordinary Shares

Country
USA
Full Time Employees
68

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

NewAmsterdam Pharma Company N.V. Ordinary Shares Earnings” Can Refer to the NewAmsterdam Pharma Company N.V. Ordinary Shares Earnings Date

Some people say “NewAmsterdam Pharma Company N.V. Ordinary Shares earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my NewAmsterdam Pharma Company N.V. Ordinary Shares position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning NewAmsterdam Pharma Company N.V. Ordinary Shares Stock on the Earnings Date

If you own NewAmsterdam Pharma Company N.V. Ordinary Shares stock (NAMS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for NewAmsterdam Pharma Company N.V. Ordinary Shares might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading NewAmsterdam Pharma Company N.V. Ordinary Shares shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More NewAmsterdam Pharma Company N.V. Ordinary Shares Earnings

You can contact us any time if you would like to ask questions about NewAmsterdam Pharma Company N.V. Ordinary Shares earnings or anything else related to the stock market.